Sponsor: 
Sanofi-Aventis Australia
Administration route: 
Intramuscular injection
Vaccine group: 
Monovalent vaccines

Registered for use in people aged ≥2 years.

Each 0.5 mL monodose pre-filled syringe contains:

  • 160 antigen units of inactivated hepatitis A virus (GBM strain)
  • 0.3 mg aluminium as aluminium hydroxide
  • 2.5 µL phenoxyethanol
  • 12.5 µg formaldehyde
  • ≤2.5 µg neomycin
  • <50 ng bovine serum albumin
  • traces of polysorbate 80

For full details, refer to the product information and consumer medicine information sheets for Avaxim vaccine available on the TGA website.

Related diseases: 
Hepatitis A

Page history

Last updated: 
4 June 2018
Last reviewed: 
4 June 2018